Section 174: Legislative Changes, Business Impact, and What Comes Next

The treatment of Section 174 research and experimental expenditures has been one of the most significant tax developments affecting innovative businesses in recent years. Changes to the rules have created cash flow, planning, and compliance challenges for many companies that invest in research, product development, software development, and other qualifying activities.

In this webinar, tax policy and industry experts discuss the evolution of Section 174, its relationship to the R&D tax credit, and the considerations businesses should evaluate when assessing the impact on their operations. Attendees will gain a better understanding of the policy landscape, the implications for innovative companies, and key factors to consider when planning for the future.